This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Diabetic Ulcer Gel Gets Black Box Warning

Posted: Friday, June 20, 2008

A black box warning has been added to the safety labeling for becaplermin gel (Regranex, Johnson & Johnson) to warn of the increased risk for cancer mortality in patients who use 3 or more tubes of the product, the US Food and Drug Administration (FDA) announced on Friday.

Diabetes Prevention Hopes Revived for Thiazolidinedione

Posted: Friday, June 20, 2008

Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.

Two Genes Connected to Autoimmune Diseases

Posted: Monday, June 16, 2008

The location on a chromosome of two specific genes has been shown to play a major role in the development of autoimmune diseases. This discovery could help develop future treatments and therapies for autoimmune diseases, such as type 1 diabetes.

Medicine Might Help Prevent Diabetic Retinopathy

Posted: Friday, June 13, 2008

Diabetics who take the drug rosiglitazone may significantly decrease the chance of visual impairments and blindness. This drug appears to fend off the common and troubling condition known as diabetic retinopathy.

Monotherapy BYETTA(R) (Exenatide) As Stand Alone Therapy

Posted: Wednesday, June 11, 2008

Submitted to FDA for Stand-Alone Therapy in Q1 2008, studies show that exenatide can lower A1c 0.7 to 0.9 points as a monotherapy.

Type 2 Patients Taking Exenatide Once Weekly Improved Glycemic Control, Weight, and Lipid Profiles

Posted: Wednesday, June 11, 2008

Amylin, Eli Lilly and Alkermes announced results from the DURATION-1 trial, a 30-week study that compared the efficacy of exenatide once weekly, a long-acting release formulation of exenatide, to BYETTA(R) (exenatide) injection.

World's largest Trial of Intensive Glucose Control in Type 2 Diabetes Shows Reduced Risk of Complications by 21%: ADVANCE Study

Posted: Wednesday, June 11, 2008

The world's largest diabetes trial has shown intensive blood glucose can reduce the risk of kidney disease by 21% with no evidence of any increased risk of death when blood glucose was intensively controlled.

Sun Light Helps Prevent Type 1 Diabetes

Posted: Thursday, June 05, 2008

Sun light, which is a major source of vitamin D, appears to lower type 1 diabetes risk for children. This discovery was recently made at the University of San Diego Moores Cancer Center.

Intensive Insulin Therapy At Diagnosis 'Slows Diabetes' Into Remisssion

Posted: Thursday, May 29, 2008

Giving newly diagnosed type 2 diabetes patients intensive insulin therapy for a few days or weeks can drive the disease into extended remission and at least partly restore â-cell function, researchers said.

Many Diabetics Don't Get Necessary Blood Pressure Treatment

Posted: Thursday, May 29, 2008

Only half of patients had their therapy changed as needed, study found. Diabetics with high blood pressure have only a 50-50 chance that their doctors will change their medications as needed or offer other treatment, a new study finds.